Patents by Inventor Nicole Wunderler

Nicole Wunderler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GM-CSF variants and methods of use
    Patent number: 11208450
    Abstract: GM-CSF variants, polynucleotides encoding them, and methods of making and using the foregoing are useful in treatment of immune-related disorders, such as inflammatory bowel disease (IBD).
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: December 28, 2021
    Assignee: Janssen Biotech, Inc.
    Inventors: Thomas Rutkoski, Alexey Teplyakov, Nicole Wunderler
  • GM-CSF Variants and Methods of Use
    Publication number: 20200148736
    Abstract: GM-CSF variants, polynucleotides encoding them, and methods of making and using the foregoing are useful in treatment of immune-related disorders, such as inflammatory bowel disease (IBD).
    Type: Application
    Filed: January 17, 2020
    Publication date: May 14, 2020
    Inventors: Thomas Rutkoski, Alexey Teplyakov, Nicole Wunderler
  • GM-CSF variants and methods of use
    Patent number: 10562948
    Abstract: GM-CSF variants, polynucleotides encoding them, and methods of making and using the foregoing are useful in treatment of immune-related disorders, such as inflammatory bowel disease (IBD).
    Type: Grant
    Filed: June 7, 2017
    Date of Patent: February 18, 2020
    Assignee: Janssen Biotech, Inc.
    Inventors: Thomas Rutkoski, Alexey Teplyakov, Nicole Wunderler
  • GM-CSF Variants and Methods of Use
    Publication number: 20170355742
    Abstract: GM-CSF variants, polynucleotides encoding them, and methods of making and using the foregoing are useful in treatment of immune-related disorders, such as inflammatory bowel disease (IBD).
    Type: Application
    Filed: June 7, 2017
    Publication date: December 14, 2017
    Inventors: Thomas Rutkoski, Alexey Teplyakov, Nicole Wunderler